$CABA

$1.35 -$0.12 (8.16%) Close

$CABA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$CABA Management Team

Dr. Steven Nichtberger

Chief Executive Officer

President

Chairman of the Board

Co-Founder

Age 63

Compensation $8.097M USD

Sex Male

Mr. Anup Marda

Chief Financial Officer

Age 47

Compensation $1.529M USD

Sex Male

Dr. Gwendolyn Binder-Scholl

President - Science and Technology

Age 50

Compensation $3.325M USD

Sex Female

Dr. David Chang

Chief Medical Officer

Age 62

Compensation $3.346M USD

Sex Male

Dr. Arun Das

Chief Business Officer

Age 35

Compensation -

Sex Male

Mr. Michael Gerard

General Counsel

Secretary

Age 45

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Steven Nichtberger Chief Executive Officer President Chairman of the Board Co-Founder	63	$8.097M USD	Male
Mr. Anup Marda Chief Financial Officer	47	$1.529M USD	Male
Dr. Gwendolyn Binder-Scholl President - Science and Technology	50	$3.325M USD	Female
Dr. David Chang Chief Medical Officer	62	$3.346M USD	Male
Dr. Arun Das Chief Business Officer	35	-	Male
Mr. Michael Gerard General Counsel Secretary	45	-	Male

Board of Directors

From the proxy statement filed Apr 28, 2026

Directors

serving now

Independent

5 of 5

stated in the proxy; 1 not stated

Average tenure

6.5 years

from year joined

CEO also chairs the board

Yes

Steven Nichtberger

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Scott Brun	58	2021 5 years	Independent	Audit Committee Science and Technology Committee	Jasper Therapeutics, Inc. (Nasdaq: JSPR), Forte Biosciences, Inc. (Nasdaq: FBRX)	$136,840
Shawn Tomasello	67	2023 3 years	Independent	Compensation Committee · Chair Science and Technology Committee	4D Molecular Therapeutics Inc. (Nasdaq: FDMT)	Not stated
Catherine Bollard	58	2019 7 years	Independent	Nominating and Corporate Governance Committee	None stated	Not stated
Richard Henriques	70	2019 7 years	Independent	Compensation Committee	None stated	Not stated
Steven Nichtberger Board chair, CEO	64	2017 9 years	Not stated	None stated	None stated	Paid as CEO
Mark Simon	64	2018 8 years	Independent	Audit Committee Compensation Committee Nominating and Corporate Governance Committee	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$CABA Management Team

Dr. Steven Nichtberger

Mr. Anup Marda

Dr. Gwendolyn Binder-Scholl

Dr. David Chang

Dr. Arun Das

Mr. Michael Gerard

Board of Directors

Related-party transactions

No related-party transactions disclosed